Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: Preliminary results

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 6, 2006, Pages 995-1002

  Saad, Wael E A ^a   Saad, Nael E A ^a   Davies, Mark G ^a   Bozorgdadeh, Adel ^a   Orloff, Mark S ^a   Patel, Nikhil C ^a   Abt, Peter L ^a   Lee, David E ^a   Sahler, Lawrence G ^a   Kitanosono, Takashi ^a   Sasson, Talia ^a   Waldman, David L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; APACHE; BLOOD CLOTTING; BLOOD TRANSFUSION; CLINICAL ARTICLE; DECOMPRESSION SURGERY; FEMALE; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LIVER DISEASE; LIVER GRAFT; MALE; MORTALITY; PRIORITY JOURNAL; REVIEW; SHUNTING; TIME SERIES ANALYSIS;

EID: 33748210700     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000223683.87894.a4     Document Type: Article

References (61)

1. Jabbour N, Gagandeep S, Mateo R, et al. Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application. Ann Surg 2004; 240:350-357.
2. Porte RJ, Hendriks HGD, Slooff MJH. Blood conservation in liver transplantation: the role of aprotinin. J Cardiothorac Vasc Anesthesia 2004; 18(suppl):S31-S37.
3. Schroeder RA, Collins BH, Tuttle-Newhall E, et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesthesia 2004; 18:438-441.
4. Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9:1320-1327.
5. Spanier TB, Klein RD, Nasraway SA, et al. Multiple organ failure after liver transplantation. Crit Care Med 1995; 23:466-473.
6. Lo CM, Fan ST, Liu CL, et al. Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 2004; 240:151-158.
7. Niemann CU, Hirose R, Stock P, et al. Intraoperative fluid management of living donor versus cadaveric liver transplant recipients. Transplant Proc 2004; 36:1466-1468.
8. Ben-Haim M, Emre S, Fishbein TM, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl 2001; 7:948-953.
9. Testa G, Malago M, Nadalin S, et al. Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl 2002; 8:340-346.
10. Haskal ZJ, Martin L, Cardella JF, et al for the Society of Interventional Radiology Standards of Practice Committee. Quality improvement guideline for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2003; 14(suppl):S265-S270.
11. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829.
12. Chung SW, Kirkpatrick AW, Kim HLN, et al. Correlation between physiological assessment and outcome after liver transplantation. Am J Surg 2000; 179:396-399.
13. Steib A, Freys G, Lehmann C, et al. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anesth 2001; 48:1075-1079.
14. Shaw BW, Wood P, Stratta RJ, et al. Stratifying the cause of death in liver transplant recipients: an approach to improving survival. Arch Surg 1989; 124:895-900.
15. Shaw BW, Wood P, Gordon RD, et al. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985; 5:385-393.
16. Starzl TE, Demetris AJ, Van-Thiel D. Medical progress: liver transplantation. N Engl J Med 1989; 321:109-129.
17. Baliga P, Merion RM, Turcotte JG, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992; 112:704-711.
18. Roberts MS, Angus DC, Bryce CL, et al. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004; 10:886-897.
19. Akyildiz M, Karasu Z, Arikan C, et al. Impact of pretransplant MELD score on transplant outcome in living donor liver transplantation. Transpl Proc 2004; 36:1442-1444.
20. Hayashi PH, Forman L, Steinberg T, et al. Model for End-stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003; 9:737-740.
21. Brown RS Jr, Kumar KS, Russo MW, et al. Model for End-stage Liver Disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing Status 2A patients. Liver Transpl 2002; 8:278-284.
22. Santori G, Andorno E, Antonucci A, et al. Potential predictive value of the MELD score for short-term mortality after liver transplantation. Transpl Proc 2004; 36:533-534.
23. Narayanan-Menon KV, Nyberg SL, Harmsen WS, et al. MELD and other factors associated with survival after liver transplantation. Am J Transpl 2004; 4:819-825.
24. Marshall JC, Lee C, Meakins JL, et al. Kupffer cell modulation of systemic immune response. Arch Surg 1987; 122:191-196.
25. Rogoff TM, Lipsky PE. Role of the Kupffer cells in local and systemic immune response. Gastroenterology 1981; 80:854-860.
26. Yoshioka K, Shinichi K, Arao M, et al. Tumor necrosis factor alpha production by peripheral blood mononuclear cell of patients with chronic liver disease. Hepatology 1989; 10:769-773.
27. McClain CJ, Cohen DA. Increase tumor necrosis factor production by monocytes in alcoholic cirrhosis. Hepatology 1989; 9:349-351.
28. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992; 216:117-134.
29. Figueras J, Llado L, Ramos E, et al. Temporary portocaval shunt during liver transplantation with vena cava preservation: results of a prospective randomized study. Liver Transpl 2001; 7:904-911.
30. Menegaux F, Baker E, Keeffe EB, et al. Impact of transjugular intrahepatic portosystemic shunt on orthotopic liver transplantation. World J Surg 1994; 18:866-870.
31. Wroblewski T, Rowinski O, Ziarkiewicz-Wroblewska B, et al. TIPS: a therapy to prevent variceal rebleeding in patients listed for liver transplantation. Transpl Proc 2002; 34:635-637.
32. Bechstein WO, Neuhaus P. A surgeon's perspective on the management of coagulation disorders before liver transplantation. Liver Transplant Surg 1997; 3:653-655.
33. Cacciarelli TV, Keeffe EB, Moore DH, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999; 134:25-29.
34. Cancemi E, Ramsay KJ, Ramsay MAE, et al. Liver transplantation and blood use: predictors and impact on outcome. Anesthesiology 1999; 89:A419.
35. Palomo-Sanchez JC, Jimenez C, Moreno-Gonzalez E, et al. Effects of intraoperative blood transfusion on postoperative complications and survival after orthotopic liver transplantation. Hepatogastroenterology 1998; 45:1026-1033.
36. Spahn DR, Casutt M. Eliminating blood transfusions. Anesthesiology 2000; 93:242-255.
37. Schroeder RA, Johnson LB, Plotkin JS, et al. Total blood transfusion and mortality after orthotopic liver transplantation. Anesthesiology 1999; 91:329-330.
38. Menegaux F, Keeffe EB, Baker E, et al. Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation. Arch Surg 1994; 129:1018-1023.
39. Millis JM, Martin P, Gomes A, et al. Transjugular intrahepatic portosystemic shunts: impact on liver transplantation. Liver Transpl Surg 1995; 1:229-233.
40. Mor E, Jennings L, Gonwa TA, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet 1993; 176:219-227.
41. Seiders E, Peeters PMJG, TenVergert EM, et al. Prognostic factors for longterm actual patient survival after orthotopic liver transplantation in children. Transplantation 2000; 70:1448-1453.
42. Porte RJ, Molenaar IQ, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicenter randomized double-blind study. Lancet 2000; 355:1303-1309.
43. Findlay JY, Rettke SR. Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. J Clin Anesthesia 2000; 12:319-323.
44. Hendriks HG, Van der Meer J, de Wolf JT, et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int 2005; 17:673-679.
45. Abou Jaoude MM, Almawi WY. Liver transplantation in patients with previous portasystemic shunt. Transpl Proc 2001; 33:2723-2725.
46. Langnas AN, Marujo WC, Stratta RJ, et al. Influence of a prior porta-systemic shunt on outcome after liver transplantation. Am J Gastroenterol 1992; 87:714-718.
47. Brems JJ, Hiatt JR, Klein AS, et al. Effect of prior portasystemic shunt on subsequent liver transplantation. Ann Surg 1989; 209:51-56.
48. Rubio Gonzalez EE, Moreno Planas JM, Jimenez Garrido MC, et al. Results of liver transplantation in patients with previous portosystemic shunts. Transpl Proc 2005; 37:1491-1492.
49. John TG, Jalan R, Stanley AJ, et al. Transjugular intrahepatic portosystemic stent-shunt insertion as a prelude to orthotopic liver transplantation in patients with severe portal hypertension. Eur J Gastroenterol Hepatol 1996; 8:1145-1149.
50. Somberg KA, Lombardero MS, Lawlor SM, et al. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. Transplantation 1997; 63:1074-1079.
51. Lerut JP, Laterre PF, Goffette P, et al. Transjugular intrahepatic portosystemic shunt and liver transplantation. Transpl Int 1996; 9:370-375.
52. Tripathi D, Therapondos G, Redhead DN, et al. Transjugular intrahepatic portosystemic stent-shunt and its effect on orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2002; 827-832.
53. Chui AK, Rao AR, Waugh RC, et al. Liver transplantation in patients with transjugular intrahepatic portosystemic shunts. Aust NZ J Surg 2000; 70:493-495.
54. Freeman RB Jr, FitzMaurice SE, Greenfield AE, et al. Is the transjugular intrahepatic portocaval shunt procedure beneficial for liver transplant recipients? Transplantation 1994; 58:297-300.
55. Zhou GW, Cai WY, Li HW, et al. Transjugular intrahepatic portosystemic shunt for liver transplantation. Hepatobil Pancreat Dis Int 2002; 1:179-182.
56. Clavien PA, Markus S, Tuttle-Newhall JE, et al. Liver transplantation complicated by misplaced TIPS in the portal vein. Ann Surg 1998; 227:440-445.
57. Goldberg MS, Weppler D, Khan FA, et al. Does transjugular intrahepatic portosystemic shunting facilitate or complicate liver transplantation? Transplant Proc 1997; 29:557-559.
58. Knechtle SJ. Portal hypertension: A multi-disciplinary approach to current clinical management. New York: Futura Publishing Company, 1998;253-263.
59. Hutchins RR, Patch D, Tibballs J, et al. Liver transplantation complicated by embedded transjugular intrahepatic portosystemic shunt: a new method for portal anastomosis - a surgical salvage procedure. Liver Transplantation 2000; 6:237-238.
60. Clark TW, Agarwal R, Haskal ZJ, et al. The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2004; 15:147-152.
61. Ozier Y, Pessione F, Samain E, et al. French study group on blood transfusion in liver transplantation: institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003; 97:671-679.